19520: Case studies: Jun 12 update

An image of a gloved hand holding a dropper tool dropping fluid in a test tray

Biotech

Explore key learnings from our strategic collaboration with leading pharma companies to develop targeted solutions.

Pharma case studies

Explore Biotech

Our biotechnology consulting team brings strategic insights that help biotech companies build value and innovate with confidence.

A close up shot of capsule pills on an assembly line

Explore Pharma

From pharmaceutical M&A to capital optimization and more, we empower the pharmaceutical industry to drive innovation and growth.

Pharma

An image of an opening of a medical scanning device

Explore MedTech

We work closely with leading and emerging companies across the medical technology industry in key areas such as M&A and supply chain.

MedTech

Real life stories

Industry insights

Where to find us

Key contact

Accelerated access to novel cancer therapies at Moores Cancer Center

How a B2B company drove engagement by transforming its D2C platform

How tech and trust transformed a tax operating model

Global pharmaceutical player Boehringer Ingelheim is reimagining its tax operating model to boost quality and efficiency.

Merck Animal Health modernized its HomeAgain e-commerce site to offer customers a robust online experience that drives growth and expansion.

Moores Cancer Center accelerated activation of high-priority clinical trials by leveraging the EY Clinical Trial Fast Lane solution.

A scientist looking in a microscope in a lab

A woman and her pug dog working on the computer at home

An image of a doctor reviewing results with a female patient in an exam room

Takeda Business Solutions fast-tracked its digitalization evolution through an innovative top-down and bottom-up journey.

What going digital means for Takeda

A scientist peering through the binoculars of a scientific microscope

To unlock the potential of AI, pharmaceutical manufacturers need a robust data foundation to drive success.

Why ‘AI by design’ is foundational to pharmaceutical manufacturing

people in lab uniforms working behind machines with microscopes

The “golden batch” approach is poised to revolutionize pharma manufacturing by setting the standard for an ideal production run.

How to reach gold-standard operations in pharmaceutical manufacturing

Image of a futuristic medical lab with AI powered equipment

Discover key insights and unique perspectives on leading solutions and top pharma industry trends.

Pharma thought leadership

Watch for us in market at key industry events or join the conversation via our webcast platform as EY thought leaders share new insights on the latest pharma trends.

Pharma events and webcasts

Pharma contact

Arda Ural, PhDEY Americas Life Sciences Sector LeaderErnst & Young LLP

A portrait of Arda Ural, EY Americas Life Sciences Sector Leader Ernst & Young LLP

AI can help biopharma companies identify M&A targets to build up their R&D pipelines as they face a “patent cliff” for existing treatments.

How AI can form the foundation for an always-on biopharma deal radar

woman with glasses analyzing data on computer screen in a dim office setting

Arda Ural, PhDEY Americas Life Sciences Sector LeaderErnst & Young LLP

Biotech contact

Watch for us in market at key industry events or join the conversation via our webcast platform as EY thought leaders share new insights on the latest biotechnology trends.

Biotech events and webcasts

Discover key insights and unique perspectives on leading solutions, top biotech trends and industry-transforming issues.

Biotech thought leadership

EY teams helped the biopharma company solve operational and financial challenges, helping it to focus on groundbreaking drug research.

How IntraBio's finance transformation fueled its global expansion

Close up of a scientist's hands pipetting a sample into a multi well plate for dna analysis

Strategy in Action, a CEO series by EY-Parthenon.

CEO of Bayer AG on mission-first strategy

The pharmaceutical company sought to improve site relationships and drive industry-leading practices.

Bayer's journey to becoming a preferred partner in clinical trials

A patient being pushed by a nurse in a wheelchair talking to a doctor in a hospital hallway

Explore key learnings from our strategic collaboration with leading biotech companies to develop targeted solutions.

Biotech case studies

Key contact

Where to find us

Industry insights

Real life stories

John BabittEY Global MedTech Leader Ernst & Young LLP

MedTech contact

Learn more

Dana Point, CA

March 16-20, 2026

LSI USA '26 Emerging MedTech Summit

Watch for us in market at key industry events or join the conversation via our webcast platform as EY thought leaders share new insights on the latest MedTech industry trends.

MedTech events and webcasts

Discussion with executive leaders from top Life Sciences companies.

Pursuing the right deals now to deliver value into the future

A close-up image of a person using a template to analyze data

Industry players walk a narrow path between converging topline and bottom-line pressures.

MedTech continues to drive innovation amid ongoing industry challenges

A close-up image of a hand holding a microchip with a two prong instrument

Reigniting growth and expanding markets.

Pulse of the MedTech Industry Report 2025

An image of a scientist wearing a lab coat and goggles interacting with a virtual reality model of a human skeleton

Discover key insights and unique perspectives on leading solutions and top MedTech industry trends.

MedTech thought leadership

A supply chain transformation enabled more personalized care for over 78 million patients.

How Medtronic’s optimized supply chain gets products to patients in need

Medics and patient in during an oncology treatment

Hear from John Babitt, EY Global MedTech Leader, as he shares important highlights on the state of the industry.

Pulse on MedTech – February 2026

lab technician wearing lab coat and VR glasses examining a 3D digital skeleton

Explore key learnings from our strategic collaboration with leading MedTech companies to develop targeted solutions.

MedTech case studies

Key contact

Where to find us

Industry insights

Real life stories

Learn more

San Diego, CA

June 22-25, 2026

Bio International Convention

Learn more

New Orleans, LA

May 3-6, 2026

2026 PMSA Annual Conference

GenAI has helped organize the agronomic knowledge in a way that makes retrieval easy and accessible.

Large language models are planting the seeds of the future

AI plant experts reviewing data in a cornfield

Strategy in Action, a CEO series by EY-Parthenon.

CEO of Bayer AG on mission-first strategy

EY solutions helped transform and improve its clinical site invoicing and payment approach.

Leading pharma company sought to improve site relationships and drive leading practices

A nurse pushing patient in wheelchair talking to a doctor in a hospital hallway

Learn more

Las Vegas NV

April 26-30 2026

ASEMBIA Summit

Learn more

Philadelphia, PA

March 23-25, 2026

Informa Connect Accounting & Reporting Congress

Our deep experience helped a pharma company establish a global footprint.

How confident are you turning your vision into value?

A scientist in a face mask taking notes while conducting a test in a medical laboratory

Discussion with executive leaders from top Life Sciences companies.

Pursuing the right deals now to deliver value into the future

Many smart medical devices in health care today are not designed with security in mind, exposing sensitive data to risk.

How organizations can deliver medical device security the care it needs

For top performers, R&D investments fuel growth, increase investor confidence and unlock total shareholder return.

Investing in innovation: unlocking value in MedTech

An image of a female doctor wearing gloves while analyzing a mold on a computer screen

Discover how EY teams helped Sigma simplify and standardize to boost availability and cut inventory by 20%.

How Sigma, an Australian pharmaceutical company, transformed its supply chain

An image of a pharmacist examining a machine in a room surrounded by shelves full of medicines.

Texas remains a compelling microcosm within the global biotech sector, which is marked by both uncertainty and promise.

EY Biotech Beyond Borders Report 2025: Texas Edition

A shot from the sky overlooking the Margaret Hunt Hill bridge and downtown Dallas, USA

An EY-Parthenon team helped BMS establish a cash leadership office as part of an award-winning Treasury transformation. Learn more in this case study.

How Bristol Myers Squibb overhauled working capital to fund its future

An image of two colleagues working together in a conference room in a modern workplace setting.

Learn more

As the need for enhanced traceability intensifies, modern solutions can help organizations drive patient safety and product integrity.

How to enhance traceability in the life sciences supply chain

Assembly line in factory glass vials being filled with pills and tablets

The EY 2026 Firepower M&A report finds life sciences companies recognizing the need to accelerate their dealmaking strategies to succeed in an increasingly competitive environment.

EY Firepower Report: Life Sciences Dealmaking and M&A Growth Strategy

A vibrant, long‑exposure view of a futuristic tunnel with streaks of red and blue lights creating a sense of high‑speed motion

Acquiring pre-commercial assets is critical to fill biopharma development pipelines. The deals require a tailored integration approach.

How biopharmas can better integrate pre-commercial acquisitions

AI in biopharma must go beyond operational efficiencies and cost savings become a strategic engine driving mission-centric growth and innovation.

How AI in biopharma drives mission‑focused growth

Revolutionizing healthcare through medical tech

AI in biopharma must go beyond operational efficiencies and cost savings become a strategic engine driving mission-centric growth and innovation.

How AI in biopharma drives mission-focused growth

Lab technician wearing lab coat, goggles and gloves analyzing data on a digital screen

The MedTech Conference

Boston, MA

October 18-21, 2026

Learn more

AI driven, digitally connected supply chains are becoming essential to keeping clinical trials on track amid growing complexities.

How digital, AI-enabled supply chains can strengthen clinical trials

Pharmaceutical medicine tablet pill background at pharmacy industry manufacture

New York, NY

June 17, 2026

Planning Reimagined: Creating an AI-Powered Supply Chain EY Seminar

Learn more

New York, NY

June 17, 2026

Planning Reimagined: Creating an AI-Powered Supply Chain EY Seminar

Learn more

New York, NY

June 17, 2026

Planning Reimagined: Creating an AI-Powered Supply Chain EY Seminar

Pharmaceuticals manufacturers are facing increasing compliance regulations and challenges from global production.

Why it’s time for pharma leaders to rethink quality

In the 36th annual EY Biotech Beyond Borders report, long-range observations find the industry’s fundamentals remain very strong.

EY Biotech Beyond Borders Report 2026

Group of scientists working in a laboratory

As biopharma companies look to new markets for growth, leaders need to tailor their expansion efforts to the nuances of each market.

Key steps for improving biopharma expansion into new markets

A close up shot of a chemist wearing blue latex gloves and a white lab coat working in a laboratory

Life sciences is no longer just about molecules and microscopes. It’s about data, digital ecosystems and the ability to connect dots at lightning speed.

How can the life sciences industry go from fragmentation to creating a new fabric for innovation?